US Drug Recall Register

Is Pine recalled?

Yes — there is an active recall. 82 ongoing FDA recalls mention Pine (685 total). Check the affected lots below.

Recalls are matched by product description. A recall usually affects specific lots, not every package of Pine. “Active” means an FDA recall is still ongoing; “closed” means it was terminated or completed.

Class II · Moderate risk Terminated

Clozapine Tablets USP

Reason Microbial Contamination of Non-Sterile Products

Teva Pharmaceuticals USA NDC 0093-4359-01 D-0705-2017
Class II · Moderate risk Terminated

Atropine Sulfate 0.5% Ophth

Reason Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.

Key Pharmacy and Compounding Center D-0712-2017
Class II · Moderate risk Terminated

Atropine Sulfate 0.01% Ophth

Reason Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.

Key Pharmacy and Compounding Center D-0711-2017
Class III · Low risk Terminated

Olanzapine Tablets

Reason Failed Impurities/Degradation Specifications: out of specification results for the related substances test parameter (impurities).

Sun Pharmaceutical Industries, Inc. NDC 62756-556-83 D-0702-2017
Class III · Low risk Terminated

Olanzapine Tablets

Reason Failed Impurities/Degradation Specifications: out of specification results for the related substances test parameter (impurities).

Sun Pharmaceutical Industries, Inc. NDC 62756-554-83 D-0701-2017
Class III · Low risk Terminated

Olanzapine Tablets

Reason Failed Impurities/Degradation Specifications: out of specification results for the related substances test parameter (impurities).

Sun Pharmaceutical Industries, Inc. NDC 62756-553-83 D-0700-2017
Class III · Low risk Terminated

Olanzapine Tablets

Reason Failed Impurities/Degradation Specifications: out of specification results for the related substances test parameter (impurities).

Sun Pharmaceutical Industries, Inc. NDC 62756-551-18 D-0699-2017
Class III · Low risk Terminated

Isopto Carpine

Reason Failed Impurities/Degradation Specifications.

Novartis Pharmaceuticals Corp. NDC 0998-0206-15 D-0678-2017
Class I · High risk Ongoing

EpiPen Jr. 2-Pak

Reason Defective Delivery System; reports of the device failing to activate which could result in a patient not receiving medication

Meridian Medical Technologies a Pfizer Company NDC 49502-500-02 D-0691-2017
Class I · High risk Ongoing

EpiPen 2-Pak

Reason Defective Delivery System; reports of the device failing to activate which could result in a patient not receiving medication

Meridian Medical Technologies a Pfizer Company NDC 49502-500-02 D-0690-2017
Class III · Low risk Terminated

Adalat CC

Reason Cross Contamination with another product:residual powder found in inlet air duct identified as sorafenib

Alvogen, Inc D-0635-2017
Class III · Low risk Terminated

Adalat CC

Reason Cross Contamination with another product:residual powder found in inlet air duct identified as sorafenib

Alvogen, Inc D-0634-2017
Class III · Low risk Terminated

Adalat CC

Reason Cross Contamination with another product:residual powder found in inlet air duct identified as sorafenib

Alvogen, Inc D-0633-2017
Class III · Low risk Terminated

Adalat CC

Reason Cross Contamination with another product:residual powder found in inlet air duct identified as sorafenib

Alvogen, Inc D-0632-2017
Class III · Low risk Terminated

Nifedipine Extended-Release Tablets

Reason Cross Contamination with another product:residual powder found in inlet air duct identified as sorafenib

Alvogen, Inc NDC 47781-370-01 D-0631-2017
Class III · Low risk Terminated

Nifedipine Extended-Release Tablets

Reason Cross Contamination with another product:residual powder found in inlet air duct identified as sorafenib

Alvogen, Inc NDC 47781-369-01 D-0630-2017
Class III · Low risk Terminated

Adalat CC

Reason Cross Contamination with another product:residual powder found in inlet air duct identified as sorafenib

Alvogen, Inc NDC 50419-702-05 D-0629-2017
Class III · Low risk Terminated

Adalat CC

Reason Cross Contamination with another product:residual powder found in inlet air duct identified as sorafenib

Alvogen, Inc NDC 50419-701-05 D-0628-2017
Class III · Low risk Terminated

Nifedipine Extended-Release Tablets

Reason Cross Contamination with another product:residual powder found in inlet air duct identified as sorafenib

Alvogen, Inc NDC 47781-368-01 D-0627-2017
Class II · Moderate risk Terminated

Atropine Sulfate all strengths

Reason Labeling: Not Elsewhere Classified: Products may contain synthetic latex and/or natural latex.

Advanced Pharma Inc. D-0840-2017
Class II · Moderate risk Terminated

Nicardipine HCl all strengths

Reason Labeling: Not Elsewhere Classified: Products may contain synthetic latex and/or natural latex.

Advanced Pharma Inc. D-0834-2017
Class II · Moderate risk Terminated

Epinephrine HCl all strengths

Reason Labeling: Not Elsewhere Classified: Products may contain synthetic latex and/or natural latex.

Advanced Pharma Inc. D-0828-2017
Class II · Moderate risk Terminated

Norepinephrine Bitartrate all strengths

Reason Labeling: Not Elsewhere Classified: Products may contain synthetic latex and/or natural latex.

Advanced Pharma Inc. D-0827-2017
Class II · Moderate risk Terminated

Mirtazapine Tablets

Reason Presence of Foreign Tablets/Capsules; possibility of Glipizide 10 mg tablets commingled

Mylan Institutional, Inc. (d.b.a. UDL Laboratories) NDC 51079-088-20 D-0493-2017